की कीमत क्या है Miravant Medical Technologies Inc. (MRVT)

का मूल्य Miravant Medical Technologies Inc. (MRVT) है $0.00001

का बाजार पूंजीकरण क्या है Miravant Medical Technologies Inc. (MRVT)

का बाजार पूंजीकरण Miravant Medical Technologies Inc. (MRVT) है $352.62

Miravant Medical Technologies Inc. (MRVT) लाभांश

Miravant Medical Technologies Inc. operates as a specialized firm dedicated to pharmaceutical research and development. A cornerstone of its work involves PhotoPoint, an innovative photodynamic therapy designed to eradicate cancerous cells when exposed to light. Furthermore, the company manufactures the essential light-generating and light-delivery devices required for this treatment. Miravant's product pipeline includes several therapeutic agents: PHOTREX, which is aimed at treating wet age-related macular degeneration (AMD); MV9411, a photoreactive compound developed for managing plaque psoriasis; MV0633, which targets conditions like atherosclerosis, vulnerable atherosclerotic plaque, and restenosis; MV2101, designed to address vascular access graft disease in hemodialysis patients; and MV6401, a treatment under development for solid tumors. The organization, originally established as PDT, Inc., officially adopted its current name, Miravant Medical Technologies Inc., in September of 1997. Founded in 1989, it maintains its corporate headquarters in Santa Barbara, California.

वर्ष	लाभांश (स्टॉक स्प्लिट समायोजित)	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

लाभांश (स्टॉक स्प्लिट समायोजित)

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष	लाभांश	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

लाभांश

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

कंपनी	लाभांश भुगतान की संख्या	देश
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.00%	IN

कंपनी

लाभांश भुगतान की संख्या

देश